Aspen Pharmacare Holdings Limited (JSE:APN)

Aspen Pharmacare Holdings Ratios and Metrics

Market cap in millions ZAR. Fiscal year is July - June.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 4, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	66,794	53,079	103,810	81,701	62,047	73,836
Market Cap Growth	48.04%	-48.87%	27.06%	31.68%	-15.97%	12.88%
Enterprise Value	94,117	81,746	128,328	100,452	81,357	101,518
Last Close Price	150.43	116.89	224.02	172.83	127.83	147.38

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 4, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
PE Ratio	-	-	23.57	15.63	9.56	15.36
Forward PE	12.54	9.58	12.68	10.44	7.34	11.63
PS Ratio	1.57	1.22	2.32	2.01	1.61	1.96
PB Ratio	0.82	0.63	1.22	0.95	0.88	1.13
P/TBV Ratio	1.98	3.71	7.46	4.45	4.68	9.88
P/FCF Ratio	15.10	20.55	33.40	24.83	18.19	15.45
P/OCF Ratio	9.64	10.29	16.68	14.80	11.55	10.82
PEG Ratio	1.28	63.89	0.89	0.66	0.46	1.27

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 4, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
EV/Sales Ratio	2.21	1.89	2.87	2.47	2.11	2.69
EV/EBITDA Ratio	12.00	9.60	12.49	9.86	8.19	11.06
EV/EBIT Ratio	15.57	11.69	14.47	11.25	9.31	12.52
EV/FCF Ratio	21.27	31.65	41.29	30.53	23.85	21.24

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 4, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Debt / Equity Ratio	0.41	0.43	0.43	0.34	0.31	0.38
Debt / EBITDA Ratio	4.20	4.13	3.47	2.82	2.20	2.66
Debt / FCF Ratio	7.45	13.98	11.73	8.90	6.52	5.21
Net Debt / Equity Ratio	0.34	0.35	0.28	0.21	0.23	0.25
Net Debt / EBITDA Ratio	3.59	3.49	2.35	1.80	1.62	1.78
Net Debt / FCF Ratio	6.18	11.50	7.76	5.58	4.71	3.42
Asset Turnover	0.32	0.32	0.33	0.33	0.35	0.31
Inventory Turnover	1.42	1.35	1.35	1.24	1.40	1.34
Quick Ratio	1.03	1.17	1.06	1.06	0.79	0.52
Current Ratio	3.64	2.21	1.81	1.92	1.48	0.89
Return on Equity (ROE)	-2.17%	-1.28%	5.15%	6.65%	9.50%	7.12%
Return on Assets (ROA)	2.85%	3.18%	4.06%	4.54%	4.94%	4.17%
Return on Invested Capital (ROIC)	5.57%	6.26%	6.40%	7.43%	8.25%	6.97%
Return on Capital Employed (ROCE)	5.40%	5.90%	7.70%	8.00%	9.90%	11.10%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 4, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Earnings Yield	-2.99%	-2.04%	4.24%	6.40%	10.46%	6.51%
FCF Yield	6.62%	4.87%	2.99%	4.03%	5.50%	6.47%
Dividend Yield	1.43%	1.80%	1.60%	1.98%	2.55%	1.78%
Payout Ratio	-	-	34.63%	27.83%	18.43%	-
Buyback Yield / Dilution	-0.03%	0.04%	-	1.94%	0.77%	-
Total Shareholder Return	1.40%	1.85%	1.60%	3.92%	3.32%	1.78%

Data Source: S&P Global Market Intelligence Last updated: Mar 3, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 5, 2026

Data Sources Report a data error